Medicxi Growth I LP 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-10 3:21 pm Purchase |
2021-11-02 | 13D | Aura Biosciences, Inc. AURA |
Medicxi Growth I LP | 3,039,892 10.700% |
3,039,892 (New Position) |
Filing |